Xspray Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	120.72	153.75	208.24	166.3	120.17	271.88
Cash & Short-Term Investments	120.72	153.75	208.24	166.3	120.17	271.88
Cash Growth	-3.98%	-26.17%	25.21%	38.39%	-55.80%	-16.50%
Other Receivables	3.17	3.84	4.02	4.17	2.59	2.5
Receivables	3.17	3.84	4.02	4.17	2.59	2.5
Inventory	22.93	22.3	20.34	43.78	8.55	6.2
Prepaid Expenses	3.1	3.01	2.48	3.57	0.93	1.48
Other Current Assets	-	0	0	-	-0	-0
Total Current Assets	149.92	182.9	235.07	217.82	132.23	282.07
Property, Plant & Equipment	68.95	70.99	79.18	107.65	64.6	44.6
Long-Term Investments	0	0	0	0	0	0
Long-Term Deferred Charges	514.24	512.19	478.93	436.78	385.6	296.24
Other Long-Term Assets	3.29	3.27	3.17	3.02	3	-
Total Assets	736.39	769.35	796.34	765.26	585.43	622.9
Accounts Payable	3.88	3.32	17.08	12.47	14.79	16.87
Accrued Expenses	14.65	11.85	18.63	16.31	11.41	10.3
Short-Term Debt	122.11	-	96	-	-	-
Current Portion of Leases	5.36	5.36	5.11	4.86	1.57	2.05
Other Current Liabilities	0.65	1.13	9.31	6.26	1.09	0.75
Total Current Liabilities	146.64	21.66	146.14	39.9	28.85	29.97
Long-Term Debt	-	121.32	-	-	-	-
Long-Term Leases	20.39	21.72	27.11	31.95	0.56	1.19
Other Long-Term Liabilities	-0	-	-0	-	-	-
Total Liabilities	167.03	164.7	173.25	71.85	29.41	31.15
Common Stock	41.74	41.74	37.14	31.25	22.68	20.68
Additional Paid-In Capital	1,574	1,574	1,425	1,216	907.42	813.48
Retained Earnings	-1,047	-1,012	-840.25	-554.72	-374.08	-242.41
Comprehensive Income & Other	0.68	0.55	1	0.79	-	-
Shareholders' Equity	569.36	604.65	623.1	693.41	556.02	591.75
Total Liabilities & Equity	736.39	769.35	796.34	765.26	585.43	622.9
Total Debt	147.85	148.39	128.22	36.81	2.13	3.23
Net Cash (Debt)	-27.13	5.35	80.02	129.5	118.04	268.65
Net Cash Growth	-	-93.31%	-38.21%	9.70%	-56.06%	-16.23%
Net Cash Per Share	-0.69	0.14	2.41	4.87	5.60	13.96
Filing Date Shares Outstanding	41.74	41.74	37.14	31.25	22.68	20.68
Total Common Shares Outstanding	41.74	41.74	37.14	31.25	22.68	20.68
Working Capital	3.27	161.23	88.93	177.91	103.38	252.1
Book Value Per Share	13.64	14.49	16.78	22.19	24.52	28.61
Tangible Book Value	569.36	604.65	623.1	693.41	556.02	591.75
Tangible Book Value Per Share	13.64	14.49	16.78	22.19	24.52	28.61
Machinery	-	47.97	51.5	52.12	49.82	46.96
Construction In Progress	-	41.39	41.39	59.37	46.57	20.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.